Sponsored
In this video, Dr Graff talks about how the treatment landscape for CLL has evolved in recent years, especially with the introduction of acalabrutinib.
Sponsored
In this video, Dr Goy discusses recent innovations in the treatment of patients with MCL.
Mridula George, MD, Rutgers Cancer institute of New Jersey, discusses the addition of HER2 targeted agents within the last two decades that have been studied in the metastatic, adjuvant, and the…
Dr Stull discusses the INSIGHT MM observational study examining ixazomib plus lenalidomide and dexamethasone for relapsed/refractory MM.
Mridula George, MD, Rutgers Cancer Institute of New Jersey, discusses her approach of early-stage HER2 positive breast cancer treatment.
Rachel McConachie, RN, BSN, Dignity Health Cancer Institute of Greater Sacramento, discusses how her cancer center has adapted to providing patients with telemedicine-driven genetic counseling.
Teresa Boitano, MD, discusses an analysis comparing minimally-invasive hysterectomy vs open radical hysterectomy for early-stage cervical cancer.
Pek Lum, PhD, discusses an AI-driven pharmaceutical company's efforts of mitigating cancer therapy toxicities through an AI engine.
In part 1 of this video series, David Ilson, MD, PhD, reviews recent immunotherapy updates in GEJ/gastric cancer.
In part 2 of this video series, David Ilson, MD, PhD, discusses approvals and advancements in the immunotherapy space for GEJ/GI cancer.
Stay in the know.
OncNet Newsletter